Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Pathogenesis of IgA nephropathies]

J C Davin1

  • 1l'Université de Liège.

Revue Medicale De Liege
|February 2, 1999
PubMed
Summary

In IgA nephropathy, kidney function loss stems from mesangial cell matrix overproduction. This is driven by IgA-containing immune complexes (IgA-CC) and undergalactosylated IgA, impacting liver clearance.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Skin manifestations in vasculitis and erythema nodosum.

Clinical and experimental rheumatology·2006
Same author

EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides.

Annals of the rheumatic diseases·2005
Same author

Clear peritoneal effluent in a child on CCPD with a phlegmonous appendicitis.

Pediatric nephrology (Berlin, Germany)·2005
Same author

[Kidney transplant survival rates and surgical complications in kidney transplants in children; experiences in the Emma Children's Hospital AMC].

Nederlands tijdschrift voor geneeskunde·2005
Same author

Levamisole in steroid-sensitive nephrotic syndrome of childhood: the lost paradise?

Pediatric nephrology (Berlin, Germany)·2004
Same author

Children with chronic renal failure have reduced numbers of memory B cells.

Clinical and experimental immunology·2004

Area of Science:

  • Nephrology
  • Immunology
  • Genetics

Context:

  • IgA nephropathy (IgAN) is a primary glomerulonephritis characterized by IgA deposition in the kidney's mesangial area.
  • Mesangial cell activation and extracellular matrix overproduction are key drivers of kidney function decline in IgAN.
  • Elevated plasma levels of IgA-containing circulating immune complexes (IgA-CC) are observed in IgAN patients.

Purpose:

  • To elucidate the mechanisms linking genetic factors, IgA abnormalities, and kidney damage in IgA nephropathy.
  • To understand the role of undergalactosylated IgA in disease pathogenesis and liver clearance.
  • To investigate the contribution of IgA-CC to mesangial matrix expansion.

Summary:

  • Loss of kidney function in IgA nephropathy is attributed to matrix overproduction by mesangial cells.
  • Mesangial cells are stimulated by deposited IgA circulating complexes (IgA-CC) in the glomeruli.
  • High IgA-CC plasma levels are partly due to genetically driven overproduction of undergalactosylated IgA, which is poorly cleared by the liver.

Impact:

  • Provides insights into the pathogenesis of IgA nephropathy, potentially identifying new therapeutic targets.
  • Highlights the significance of specific IgA glycoforms and their clearance in kidney disease.
  • May lead to strategies for managing IgA nephropathy by targeting IgA production or clearance mechanisms.

Related Experiment Videos